Xcout Intel
Shennon Biotechnologies Inc.
Shennon Biotechnologies Inc. is a biotechnology company that develops drugs to treat cancer and autoimmune diseases. It utilizes a proprietary platform called TCELERATOR to map and profile millions of single cell-cell interactions, combining ultrafast screening with AI models to identify novel therapeutic targets.
Subscribe to see Shennon Biotechnologies Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Shennon Biotechnologies Inc. at a glance
Shennon Biotechnologies Inc. is a biotech company headquartered in United States. Its most recent funding round, Seed, raised $13M in March 2023. Xcout tracks 3 named people at Shennon Biotechnologies Inc., including Cyril Konto, MD (Chief Executive Officer). Xcout recorded 11 job postings from Shennon Biotechnologies Inc. in the last 90 days.
Shennon Biotechnologies Inc. leadership
- Cyril Konto, MDChief Executive Officer
- Chad PutnamFractional Chief Financial Officer
- LI SUNFounder/CEO
Shennon Biotechnologies Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $13M | 1 named | |
| SEC Form D filing | $7.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Shennon Biotechnologies Inc.
Xcout recorded 11 job postings from Shennon Biotechnologies Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Shennon Biotechnologies Inc.'s hiring signals →
Investors
Shennon Biotechnologies Inc. competitors
A few of Shennon Biotechnologies Inc.'s closest competitors — see the full list of competitors and alternatives →
Ditto Biosciences is a company headquartered in San Francisco, US, that focuses on drug discovery. The company is involved in identifying proteins that could lead to new drugs for patients with autoimmune diseases.
Q-Immune, Inc. provides real-time protein network analysis for CAR-T cells to predict efficacy, optimize CAR-T design, and improve immunotherapy outcomes. The company serves researchers and developers in oncology, autoimmune, and neuroscience fields by generating data to model and predict cellular behavior.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Nimbus Therapeutics is a biotechnology company that uses structure-based drug discovery and computational chemistry to develop small-molecule medicines. It focuses on therapeutic areas including oncology, autoimmune disease, and metabolic disorders, serving patients through internally developed programs and pharmaceutical partnerships.
Get Shennon Biotechnologies Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Shennon Biotechnologies Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Shennon Biotechnologies Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access